Recent Analysts’ Ratings Updates for Cooper Companies (COO)

A number of research firms have changed their ratings and price targets for Cooper Companies (NASDAQ: COO):

• 12/11/2024 – Cooper Companies was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.
• 12/6/2024 – Cooper Companies had its price target raised by analysts at Wells Fargo & Company from $115.00 to $118.00. They now have an “overweight” rating on the stock.
• 12/6/2024 – Cooper Companies had its “hold” rating reaffirmed by analysts at Needham & Company LLC.
• 12/6/2024 – Cooper Companies had its price target lowered by analysts at Morgan Stanley from $104.00 to $102.00. They now have an “equal weight” rating on the stock.
• 12/6/2024 – Cooper Companies had its price target lowered by analysts at Citigroup Inc. from $116.00 to $115.00. They now have a “buy” rating on the stock.
• 12/3/2024 – Cooper Companies was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
• 11/27/2024 – Cooper Companies had its “hold” rating reaffirmed by analysts at Needham & Company LLC.
• 11/20/2024 – Cooper Companies was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.
• 11/14/2024 – Cooper Companies was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
• 11/8/2024 – Cooper Companies was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.

Cooper Companies Stock Performance

Shares of COO stock traded down $0.87 during mid-day trading on Monday, reaching $93.98. 1,963,229 shares of the company’s stock traded hands, compared to its average volume of 1,167,068. The Cooper Companies, Inc. has a 12 month low of $84.76 and a 12 month high of $112.38. The firm has a 50 day moving average price of $103.49 and a two-hundred day moving average price of $98.97. The firm has a market capitalization of $18.76 billion, a PE ratio of 48.19, a price-to-earnings-growth ratio of 2.52 and a beta of 0.97. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same period in the prior year, the company posted $0.87 EPS. The firm’s revenue for the quarter was up 9.8% compared to the same quarter last year. On average, research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Insider Buying and Selling

In other Cooper Companies news, CEO Albert G. White III sold 114,992 shares of the business’s stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the sale, the chief executive officer now owns 165,273 shares in the company, valued at approximately $18,267,624.69. The trade was a 41.03 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.00% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of COO. Point72 Asset Management L.P. lifted its stake in shares of Cooper Companies by 480.1% in the 2nd quarter. Point72 Asset Management L.P. now owns 937,806 shares of the medical device company’s stock valued at $81,870,000 after purchasing an additional 776,140 shares during the last quarter. Victory Capital Management Inc. raised its stake in shares of Cooper Companies by 23.0% in the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock valued at $435,856,000 after acquiring an additional 737,726 shares during the period. Magnetar Financial LLC acquired a new stake in Cooper Companies in the 2nd quarter valued at approximately $63,822,000. TD Asset Management Inc purchased a new stake in Cooper Companies in the second quarter valued at approximately $53,045,000. Finally, Impax Asset Management Group plc lifted its stake in Cooper Companies by 31.0% during the second quarter. Impax Asset Management Group plc now owns 2,359,798 shares of the medical device company’s stock worth $205,511,000 after purchasing an additional 558,886 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.